Sarah Connolly1, Jonathan M Carlson2, Malinda Schaefer1, Alfred Bere1, William Kilembe3, Susan Allen3,4,5, Eric Hunter1,3,5. 1. Emory Vaccine Center, Yerkes National Primate Research Center, Emory University, Atlanta, Georgia. 2. Microsoft Research, Redmond, Washington, USA. 3. Zambia-Emory HIV Research Project, Lusaka, Zambia. 4. Department of Global Health, Rollins School of Public Health. 5. Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA.
Abstract
OBJECTIVE S: We investigated the relationship between human leukocyte antigen (HLA)-associated preadaptation for the entire subtype C HIV-1 proteome of the transmitted founder virus and subsequent HIV-1 disease progression in a cohort of heterosexual linked transmission pairs in Zambia. DESIGN: An adaptation model was used to calculate an adaptation score for each virus-HLA combination in order to quantify the degree of preadaptation of the transmitted virus to the linked recipient's HLA alleles. These scores were then assessed for their relationship to viral load and longitudinal CD4+ decline in the recipient. METHODS: Viral RNA was extracted from the plasma of the donor partner and the linked recipient near the time of transmission, as well as longitudinally from the linked recipient. Viral adaptation scores were calculated for each individual and each protein in the subtype C HIV-1 proteome. RESULTS: The majority of HLA-associated sites were located in Gag, Pol and Nef; however, proportional to protein length, the accessory and regulatory proteins contained a relatively high proportion of HLA-associated sites. Over the course of infection, HLA-mediated immune adaptation increased for all proteins except Vpu and gp120. Preadaptation was positively associated with higher early set point viral load and faster CD4+ decline. When examined by protein, preadaptation in Pol and Vif were statistically significantly associated with these markers of disease progression. CONCLUSION: Adaptation in Pol had the greatest impact on viral control. Despite containing a large proportion of HLA-associated sites, Vif was the only regulatory or accessory protein for which preadaptation significantly correlated with disease progression.
OBJECTIVE S: We investigated the relationship between human leukocyte antigen (HLA)-associated preadaptation for the entire subtype C HIV-1 proteome of the transmitted founder virus and subsequent HIV-1 disease progression in a cohort of heterosexual linked transmission pairs in Zambia. DESIGN: An adaptation model was used to calculate an adaptation score for each virus-HLA combination in order to quantify the degree of preadaptation of the transmitted virus to the linked recipient's HLA alleles. These scores were then assessed for their relationship to viral load and longitudinal CD4+ decline in the recipient. METHODS: Viral RNA was extracted from the plasma of the donor partner and the linked recipient near the time of transmission, as well as longitudinally from the linked recipient. Viral adaptation scores were calculated for each individual and each protein in the subtype C HIV-1 proteome. RESULTS: The majority of HLA-associated sites were located in Gag, Pol and Nef; however, proportional to protein length, the accessory and regulatory proteins contained a relatively high proportion of HLA-associated sites. Over the course of infection, HLA-mediated immune adaptation increased for all proteins except Vpu and gp120. Preadaptation was positively associated with higher early set point viral load and faster CD4+ decline. When examined by protein, preadaptation in Pol and Vif were statistically significantly associated with these markers of disease progression. CONCLUSION: Adaptation in Pol had the greatest impact on viral control. Despite containing a large proportion of HLA-associated sites, Vif was the only regulatory or accessory protein for which preadaptation significantly correlated with disease progression.
Authors: Jaclyn K Wright; Vanessa L Naidoo; Zabrina L Brumme; Jessica L Prince; Daniel T Claiborne; Philip J R Goulder; Mark A Brockman; Eric Hunter; Thumbi Ndung'u Journal: J Virol Date: 2012-01-11 Impact factor: 5.103
Authors: Bin Li; Adrianne D Gladden; Marcus Altfeld; John M Kaldor; David A Cooper; Anthony D Kelleher; Todd M Allen Journal: J Virol Date: 2006-10-25 Impact factor: 5.103
Authors: Emily K Cartwright; Lori Spicer; S Abigail Smith; David Lee; Randy Fast; Sara Paganini; Benton O Lawson; Melon Nega; Kirk Easley; Joern E Schmitz; Steven E Bosinger; Mirko Paiardini; Ann Chahroudi; Thomas H Vanderford; Jacob D Estes; Jeffrey D Lifson; Cynthia A Derdeyn; Guido Silvestri Journal: Immunity Date: 2016-09-20 Impact factor: 31.745
Authors: A J Leslie; K J Pfafferott; P Chetty; R Draenert; M M Addo; M Feeney; Y Tang; E C Holmes; T Allen; J G Prado; M Altfeld; C Brander; C Dixon; D Ramduth; P Jeena; S A Thomas; A St John; T A Roach; B Kupfer; G Luzzi; A Edwards; G Taylor; H Lyall; G Tudor-Williams; V Novelli; J Martinez-Picado; P Kiepiela; B D Walker; P J R Goulder Journal: Nat Med Date: 2004-02-08 Impact factor: 53.440
Authors: Jessica L Prince; Daniel T Claiborne; Jonathan M Carlson; Malinda Schaefer; Tianwei Yu; Shabir Lahki; Heather A Prentice; Ling Yue; Sundaram A Vishwanathan; William Kilembe; Paul Goepfert; Matthew A Price; Jill Gilmour; Joseph Mulenga; Paul Farmer; Cynthia A Derdeyn; Jiaming Tang; David Heckerman; Richard A Kaslow; Susan A Allen; Eric Hunter Journal: PLoS Pathog Date: 2012-11-29 Impact factor: 6.823
Authors: Zabrina L Brumme; Chanson J Brumme; David Heckerman; Bette T Korber; Marcus Daniels; Jonathan Carlson; Carl Kadie; Tanmoy Bhattacharya; Celia Chui; James Szinger; Theresa Mo; Robert S Hogg; Julio S G Montaner; Nicole Frahm; Christian Brander; Bruce D Walker; P Richard Harrigan Journal: PLoS Pathog Date: 2007-07 Impact factor: 6.823
Authors: Kristin M Wall; Mubiana Inambao; William Kilembe; Etienne Karita; Bellington Vwalika; Joseph Mulenga; Rachel Parker; Tyronza Sharkey; Divya Sonti; Amanda Tichacek; Eric Hunter; Robert Yohnka; Joseph F Abdallah; Ibou Thior; Julie Pulerwitz; Susan Allen Journal: Int J Epidemiol Date: 2019-02-01 Impact factor: 7.196